KapposLMoeriDRadueEW. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. gadolinium MRI meta-analysis group. Lancet1999; 353: 964–969.
2.
FisherERudickRASimonJH. Eight-year follow-up study of brain atrophy in patients with MS. Neurology2002; 59: 1412–1420.
3.
SimonJH.Brain atrophy in multiple sclerosis: What we know and would like to know. Mult Scler2006; 12: 679–687.
4.
LucchinettiCFPopescuBFBunyanRF. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med2011; 365: 2188–2197.
5.
SaidhaSSycSBIbrahimMA. Primary retinal pathology in multiple sclerosis as detected byoptical coherence tomography. Brain2011; 134: 518–533.
6.
SaidhaSSycSBDurbinMK. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler2011; 17: 1449–1463.
RatchfordJSaidhaSSotirchosE. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology2013; 80: 47–54.
9.
TalmanLSBiskerERSackelDJ. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol2010; 67: 749–760.
10.
GreenAJMcQuaidSHauserSL. Ocular pathology in multiple sclerosis: Retinal atrophy and inflammation irrespective of disease duration. Brain2010; 133: 1591–1601.
11.
SaidhaSSotirchosESIbrahimMA. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: A retrospective study. Lancet Neurol2012; 11: 963–972.
12.
SaidhaSSotirchosESOhJ. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol2013; 70: 34–43.
